Literature DB >> 29502313

Epidemiology of malignant lymphoma and recent progress in research on adult T-cell leukemia/lymphoma in Japan.

Hiroaki Miyoshi1, Koichi Ohshima2.   

Abstract

The morbidity and mortality of disease vary according to the region and may also change over time. The morbidity and mortality of malignant lymphoma are also affected by differences in ethnicity, lifestyle habits, geographical area, and time period. Increasing research on malignant lymphoma has focused on its pathophysiology, diagnosis, and therapeutic treatment. Recent improvements in the accuracy of clinical study, technologies such as next-generation sequencing, and the development of targeted molecular agents have also resulted in a number of excellent studies. This review summarizes the epidemiology of malignant lymphoma and highlights novel studies on adult T-cell leukemia/lymphoma recently published in Japan.

Entities:  

Keywords:  ATLL; Epidemiology; Japan

Mesh:

Year:  2018        PMID: 29502313     DOI: 10.1007/s12185-018-2430-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  20 in total

1.  PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma.

Authors:  Hiroaki Miyoshi; Junichi Kiyasu; Takeharu Kato; Noriaki Yoshida; Joji Shimono; Shintaro Yokoyama; Hiroaki Taniguchi; Yuya Sasaki; Daisuke Kurita; Keisuke Kawamoto; Koji Kato; Yoshitaka Imaizumi; Masao Seto; Koichi Ohshima
Journal:  Blood       Date:  2016-07-14       Impact factor: 22.113

2.  Expression pattern of immunosurveillance-related antigen in adult T cell leukaemia/lymphoma.

Authors:  Naoko Asano; Hiroaki Miyoshi; Takeharu Kato; Joji Shimono; Noriaki Yoshida; Daisuke Kurita; Yuya Sasaki; Keisuke Kawamoto; Koichi Ohshima; Masao Seto
Journal:  Histopathology       Date:  2018-02-21       Impact factor: 5.087

3.  Advance and stagnation in the treatment of patients with lymphoma and myeloma: Analysis using population-based cancer registry data in Japan from 1993 to 2006.

Authors:  Dai Chihara; Hidemi Ito; Koji Izutsu; Masakazu Hattori; Yoshikazu Nishino; Akiko Ioka; Tomohiro Matsuda; Yuri Ito
Journal:  Int J Cancer       Date:  2015-02-26       Impact factor: 7.396

4.  Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification.

Authors:  Sun Och Yoon; Cheolwon Suh; Dae Ho Lee; Hyun-Sook Chi; Chan Jeoung Park; Seong-Soo Jang; Hai-Rim Shin; Bong-Hee Park; Jooryung Huh
Journal:  Am J Hematol       Date:  2010-10       Impact factor: 10.047

5.  Prognostic index for chronic- and smoldering-type adult T-cell leukemia-lymphoma.

Authors:  Hiroo Katsuya; Mototsugu Shimokawa; Kenji Ishitsuka; Kazuhiro Kawai; Masahiro Amano; Atae Utsunomiya; Ryosuke Hino; Shuichi Hanada; Tatsuro Jo; Kunihiro Tsukasaki; Yukiyoshi Moriuchi; Eisaburo Sueoka; Shinichiro Yoshida; Hitoshi Suzushima; Masaharu Miyahara; Kiyoshi Yamashita; Tetsuya Eto; Junji Suzumiya; Kazuo Tamura
Journal:  Blood       Date:  2017-05-17       Impact factor: 22.113

6.  Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia/Lymphoma: ATLL-002.

Authors:  Takashi Ishida; Hiroshi Fujiwara; Kisato Nosaka; Naoya Taira; Yasunobu Abe; Yoshitaka Imaizumi; Yukiyoshi Moriuchi; Tatsuro Jo; Kenichi Ishizawa; Kensei Tobinai; Kunihiro Tsukasaki; Shigeki Ito; Makoto Yoshimitsu; Maki Otsuka; Michinori Ogura; Shuichi Midorikawa; Wanda Ruiz; Tomoko Ohtsu
Journal:  J Clin Oncol       Date:  2016-09-30       Impact factor: 44.544

7.  Variegated RHOA mutations in adult T-cell leukemia/lymphoma.

Authors:  Yasunobu Nagata; Kenji Kontani; Terukazu Enami; Keisuke Kataoka; Ryohei Ishii; Yasushi Totoki; Tatsuki R Kataoka; Masahiro Hirata; Kazuhiro Aoki; Kazumi Nakano; Akira Kitanaka; Mamiko Sakata-Yanagimoto; Sachiko Egami; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Yusuke Shiozawa; Tetsuichi Yoshizato; Hiromichi Suzuki; Ayana Kon; Kenichi Yoshida; Yusuke Sato; Aiko Sato-Otsubo; Masashi Sanada; Wataru Munakata; Hiromi Nakamura; Natsuko Hama; Satoru Miyano; Osamu Nureki; Tatsuhiro Shibata; Hironori Haga; Kazuya Shimoda; Toshiaki Katada; Shigeru Chiba; Toshiki Watanabe; Seishi Ogawa
Journal:  Blood       Date:  2015-11-16       Impact factor: 22.113

8.  Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma.

Authors:  Junichi Kiyasu; Hiroaki Miyoshi; Akie Hirata; Fumiko Arakawa; Ayako Ichikawa; Daisuke Niino; Yasuo Sugita; Yuji Yufu; Ilseung Choi; Yasunobu Abe; Naokuni Uike; Koji Nagafuji; Takashi Okamura; Koichi Akashi; Ryoichi Takayanagi; Motoaki Shiratsuchi; Koichi Ohshima
Journal:  Blood       Date:  2015-08-03       Impact factor: 22.113

9.  Distribution of malignant lymphoma in Japan: analysis of 2260 cases, 2001-2006.

Authors:  Ryosuke Aoki; Kennosuke Karube; Yasuo Sugita; Yuko Nomura; Kay Shimizu; Yoshizo Kimura; Keiko Hashikawa; Nobuko Suefuji; Masahiro Kikuchi; Koichi Ohshima
Journal:  Pathol Int       Date:  2008-03       Impact factor: 2.534

10.  Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.

Authors:  Mamiko Sakata-Yanagimoto; Terukazu Enami; Kenichi Yoshida; Yuichi Shiraishi; Ryohei Ishii; Yasuyuki Miyake; Hideharu Muto; Naoko Tsuyama; Aiko Sato-Otsubo; Yusuke Okuno; Seiji Sakata; Yuhei Kamada; Rie Nakamoto-Matsubara; Nguyen Bich Tran; Koji Izutsu; Yusuke Sato; Yasunori Ohta; Junichi Furuta; Seiichi Shimizu; Takuya Komeno; Yuji Sato; Takayoshi Ito; Masayuki Noguchi; Emiko Noguchi; Masashi Sanada; Kenichi Chiba; Hiroko Tanaka; Kazumi Suzukawa; Toru Nanmoku; Yuichi Hasegawa; Osamu Nureki; Satoru Miyano; Naoya Nakamura; Kengo Takeuchi; Seishi Ogawa; Shigeru Chiba
Journal:  Nat Genet       Date:  2014-01-12       Impact factor: 41.307

View more
  7 in total

1.  Complete response following toxic epidermal necrolysis in relapsed adult T cell leukemia/lymphoma after haploidentical stem cell transplantation.

Authors:  Satoshi Morishige; Marina Nishi; Hiroshi Saruta; Fumiko Arakawa; Yoshitaka Yamasaki; Shuki Oya; Takayuki Nakamura; Ritsuko Seki; Maki Yamaguchi; Kazutoshi Aoyama; Fumihiko Mouri; Koichi Osaki; Koichi Ohshima; Koji Nagafuji
Journal:  Int J Hematol       Date:  2019-05-31       Impact factor: 2.490

2.  Treatment of aggressive adult T-cell leukemia/lymphoma: a retrospective study in a hospital located in HTLV-1 highly endemic area.

Authors:  Daisuke Nakamura; Makoto Yoshimitsu; Tomohisa Tabuchi; Naosuke Arima; Maiko Hayashida; Hirosaka Inoue; Kakushi Matsushita; Tadashi Matsumoto; Naomichi Arima; Kenji Ishitsuka
Journal:  Int J Hematol       Date:  2019-11-12       Impact factor: 2.490

3.  Cost drivers associated with diffuse large B-cell lymphoma (DLBCL) in Japan: A structural equation model (SEM) analysis.

Authors:  Saaya Tsutsué; Shinichi Makita; Jingbo Yi; Bruce Crawford
Journal:  PLoS One       Date:  2022-05-27       Impact factor: 3.752

4.  Stem cell transplant for mantle cell lymphoma in Taiwan.

Authors:  Yu-Hung Wang; Ching-Yun Hsieh; Liang-Tsai Hsiao; Tung-Liang Lin; Yi-Chang Liu; Ming Yao; Tran-Der Tan; Bor-Sheng Ko
Journal:  Sci Rep       Date:  2022-04-05       Impact factor: 4.379

5.  A case of AITL complicated by EBV-positive B cell and monoclonal plasma cell proliferation and effectively treated with lenalidomide.

Authors:  Wataru Kishimoto; Yoko Takiuchi; Yoshiki Nakae; Sumie Tabata; Akiko Fukunaga; Naomi Matsuzaki; Yoshiaki Yuba; Toshiyuki Kitano; Nobuyoshi Arima
Journal:  Int J Hematol       Date:  2019-01-02       Impact factor: 2.319

Review 6.  Epidemiology of HTLV-1 Infection and ATL in Japan: An Update.

Authors:  Masako Iwanaga
Journal:  Front Microbiol       Date:  2020-05-29       Impact factor: 5.640

Review 7.  Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group.

Authors:  Dok Hyun Yoon; Junning Cao; Tsai-Yun Chen; Koji Izutsu; Seok Jin Kim; Yok Lam Kwong; Tong Yu Lin; Lim Soon Thye; Bing Xu; Deok Hwan Yang; Won Seog Kim
Journal:  J Hematol Oncol       Date:  2020-03-17       Impact factor: 17.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.